BioCentury
ARTICLE | Company News

PixarBio Corp. neurology news

November 25, 2013 8:00 AM UTC

PixarBio launched to develop a platform to achieve sustained release of dopamine or dopamine agonists to treat Parkinson's disease (PD). The company said the platform will have applications for other ...